Drug profile · INN
sibeprenlimab-szsi
VOYXACT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sibeprenlimab-szsi (VOYXACT) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN sibeprenlimab-szsi
Brand VOYXACT
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is sibeprenlimab-szsi?
sibeprenlimab-szsi (VOYXACT) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for sibeprenlimab-szsi?
VOYXACT is a marketed brand name for sibeprenlimab-szsi. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sibeprenlimab-szsi?
sibeprenlimab-szsi has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.